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INTRODUCTION
As diabetes progresses, a myriad of symp-
toms and signs appear in patients. Of
these, distal symmetric peripheral neu-
ropathy is one of the most devastating
and common complications (Vinik et al.,
2013). Etiology of diabetic neuropathy is
complicated, and not fully understood. Yet
strong evidence points at hyperglycemia
and glycemic control as the starting point
of the diabetic complications. For refer-
ence and details please refer to Farmer
et al. (2012).
The complexity of neuropathology
can be clearly seen in the range of
patient complains related to change in
motor, autonomic and sensory functions.
A key investigation of the underlying
neuropathology associated with sensory
polyneuropathy is the study by Shun et al.
(2004). In our opinion, it demonstrates a
superb visualization of clinically case of
neuropathology. In this opinion article,
we dissect Shun’s article and scrutinize the
findings.
CLASSIFICATION OF DIABETIC
NEUROPATHOLOGY
Neuropathology associated with dia-
betes is unequivocally an axonal issue. It
can affect autonomic, myelinated motor,
myelinated fine, or unmyelinated somatic
sensory axons (Said, 2007). In brief, dia-
betes neuropathy can be observed as
symmetric polyneuropathy of axons or
focal asymmetric neuropathy associated
with lesion and inflammation (Farmer
et al., 2012). Different pathways are impli-
cated in the development and progress
of neuropathy (Figure 1). However, it is
pivotal to bear in mind that the real culprit
behind all the neuropathology is the state
of hyperglycemia (Du et al., 2000).
Categorically, the proposed mechanis-
tic processes involved in the etiology are:
Polyol pathway, glycations end products,
protein kinase C, oxidative/ free radicals
process and mitochondrial dysfunction,
inflammatory process and deficiency of
nerve growth factors. It is not a single
cause, rather a mayhem of metabolic and
deleterious cellular processes. The overall
pathology could also be extended to tan-
gible changes in vascular structure. For a
review, please refer to Farmer et al. (2012).
Clinically, the most common form of dia-
betic polyneuropathy is usually observed
in the lower limbs, in the extended long
axons. As the degenerative process reaches
the upper body short axons, symptoms
appear in hands and finger tips (Said and
Krarup, 2013).
The symptoms can include: paresthe-
sia (numbness), allodynia, hyperalgesia
(lower pain threshold), and dysesthesia
(loss of pain sensations). Symptoms usu-
ally start in the long axons of the lower
limbs and progress upward to the short
axons of the hands and fingers. It is in fact
also named “fiber length dependent pat-
tern” as it is associated with the length of
axons (Said, 2007). The progress of neu-
ropathy seems to have different path and
mechanism in insulin dependent and type
two diabetes, there are some evidence in
literature which suggest that in prediabtic
type two patients up normal unmyelinated
c fiber changes preceding large myelinated
fiber changes (Myers and Peltier, 2013).
The presence of autonomic and vascular
neuropathy, ischemia, inflammation, and
infection can lead to the grim point of loss
of the patient’s limb.
MECHANISMS OF NERVE INJURY
The two most prominent complaints in
diabetic neuropathy are peripheral pain
(nociception) and change in touch which
includes; numbness, cold or heat sens-
ing (Bierhaus et al., 2004). Two types of
sensory axons which carry these kinds of
signals are the myelinated subtle fibers
or axons of A delta sensory type and
unmyelinated fine C fibers (Christianson
et al., 2007). In a plethora of publica-
tions, one study in fact opens the argument
of how diabetes manipulates heat, pres-
sure, and pain sensation and their thresh-
olds. A study from the laboratory of Hsieh
in 2004 elegantly and visually describes
the possible changes in neuronal sensory
structure of skin layers in diabetic neu-
ropathy. For details, please refer to Shun
et al. (2004).
THE VISUAL ART
The study by Hsieh’s laboratory in 2004
included diabetic patients with sensory
symptoms including foot with graded
stocking pattern. The researchers quanti-
fied sensory response to hot, cold, vibra-
tion, and kinaesthetic stimuli. They used
a battery of tests including skin biopsy,
immunohistochemistry, thermal sensory
analysis, and nerve conduction studies. For
details, please refer to Shun et al. (2004).
The study reports that in comparison
to normal subjects, diabetic patients had
abnormal thresholds to warm and cold
stimuli; 81.6% of diabetic patients had
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FIGURE 1 | Possible trigger and mechanism involve in development of diabetic neuropathy.
elevated warm threshold and a change
of 57.9% in cold threshold. The study
also shows a higher vibration threshold of
about 63.2% and a significant reduction
in nerve conductance speed in diabetic
patients as compared to normal subjects.
In our opinion, the striking result in
this study was the skin biopsy and histol-
ogy work. It revealed a complete change in
skin layer topography. The integumentary
system contains sensory axons which con-
duct different sensory stimuli to the spinal
cord. The array of conductance includes
touch, pressure, cold and heat, and pain,
and all are mediated by small c fibers
and or fine myelinated axons (Bril and
Buchanan, 2006; Obrosova et al., 2010).
In the study performed by Shun, two
key observations are reported. First, in
the epidermis layer of diabetic patients,
a marked reduction of nerve density and
complete denervation in some biopsies
were found. In the dermis layer, they
reported that in the control subjects,
nerves were bundled up in a network sur-
rounding the layer while in the diabetic
patients, the nerves became fragmented.
Please refer to Figure 2.
First, considering conflicting animal
model studies, this is a superb observation
in human diabetic tissue. Second, it
provides a window to the end point of
neuropathy regardless of the mechanism
of destruction during diabetes neuropathy.
Third, the study opened the question
about the fate of mechanoreceptors and
their role in degenerative diabetes, this
article will focus on specific structure but
overall mediators of mechanoreceptors
referee to Table 1.
SENSORY MACHINERIES
Morphological studies of diabetic neu-
ropathy have provided some evidence
that certain machinery used by the ner-
vous system in sensing are damaged and
their function is altered by diabetes.
Mechanoreceptors machineries found
in skin include Meissners’s corpuscles,
Pacinian, Lanceolate ending and Merkel
cells and others. As most of the com-
plications of diabetes occurs in distal
axons enervated glabrous skin, we will
only focus on Meissners’s corpuscles and
Merkel cells as the others are mainly asso-
ciated with haired skin. For an overall view
of mechanoreceptor structures found in
human refer to Table 1.
MEISSNERS’S CORPUSCLES
These are tactile afferent mediating struc-
tures found within dermal papillae. They
are conical shaped protrusions of the
dermis into the epidermis layer, with the
main structure reaching the surface of
the skin (Fleming and Luo, 2013). They
have an intriguing structure which encom-
passes all the clues to construe the etiology
of neurodegenerative process. The corpus-
cles composed at the center of stacks of
lamella are derived from Schwan cells sur-
rounded by thin fibroblast capsules. The
structure is innervated by myelinated AB
sensory fiber which loses its myelination
after traveling through the bottom third of
the corpuscle, and by unmyelinated vari-
cose afferent and non-varicose C fibers
(Paré et al., 2001). The AB fibers are low
threshold sensing fibers which project to
the dorsal horn of the spinal cord.
As summarized by Fleming and Luo
(2013), those oval machinery shaped
structures are described as having very
low threshold for sensory stimuli. They
respond to low stimulation as slow as
5Hz (Palmer and Gardner, 1990) and
they respond to an indentation of skin of
less than 10 um (Iggo and Ogawa, 1977).
For details, please refer to the review by
Fleming and Luo (2013).
Shun’s study of diabetic skin biopsy
in 2004 reported two key observations.
In some samples, a complete epidermis
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denervation was observed, and in deep
dermis, researchers reported a change in
neuronal structure from the strong bun-
dled cables of network to a scattered pat-
tern of disease state. AsMeissners’s corpus-
cles are a part of sensory apparatus which
send signals through the nerve plexus and
cables to the spinal cord, would we still
expect to have normal sensory processes if
we cut or reroute cables?
THE MERKEL CELLS
Another intriguing structure in the epi-
dermis layer of the skin are the Merkel
cells. They are part of the mechanore-
ceptors’ neuronal cells. They respond to
touch stimuli and are found in the epi-
dermal layer of fingers and feet tips. For
more details, please refer to the review
article (Fleming and Luo, 2013). Merkel
cells are innervated by long axons and
they form a network known as the Merkel
cell neurotic complex. What has been
reported in Shun’s study is that neu-
ronal axons in the dermis and epidermis
were reduced. This observation alone sug-
gests the loss of axons probably for both
the Merkel cells as well as the Meissner’s
corpuscles.
Furthermore, the presence of a scat-
tered neuronal bundle in the deep der-
mis was observed. These clues indicate
the presence of an injury to axons,
changes in neuronal guidance cues, or
changes to growth cone and trophic fac-
tors. Growth cones are located at the
tips of axons, which helps axons navi-
gate their way to targets. Many molecules
could be part of this picture. Netrins, Slits
or others, for a review please refer to
Nugent et al. (2012).
One of the hallmarks of diabetic
peripheral neuropathy is loss or change
of sensation to cold (threshold), heat, and
touch. It’s an organic damage of axons or
structure connected to axons by the dele-
terious process of hyperglycemia. Many
factors could be responsible for the insult
and change in tissue topography, such as
free radical damage, metabolic bi-products
of cell glycolysis, edema, and inflamma-
tory processes. We think Shun’s paper has
provided the first visual and pictorial evi-
dence of the axonal degenerative process in
human tissue by diabetes, a unique study
which integrates the clinical agony with
visual art.
RECENT VIEWS OF DIABETIC NEUROPATHY
An earlier European study in 16 European
countries reported that almost 25% of
type one diabetic patients developed
painful diabetic neuropathy (Tesfaye et al.,
1996). Current data provided a stagger-
ing numbers of diabetes and diabetic neu-
ropathy in different countries. According
to World Health Organization, global
diabetes prevalence is approaching 5%
worldwide (Zychowska et al., 2013). In the
United States, the diabetic prevalence is
estimated to be 23.1% in population of 60
years and older. The overall prevalence of
painful diabetic neuropathy in the United
Kingdom is about 21%, and the incidence
is reported to be much lower in type one
diabetic 13.4% in comparison to type two
diabetic 21.5% (Abbott et al., 2011). In
Korea, the prevalence was reported to vary
from 13.1 to 61.8% (Won et al., 2014).
A very similar results were observed
In developing countries, diabetic neu-
ropathy estimate is about 24% (Katulanda
et al., 2012). The above data, shows how
significant is the prevalence of diabetes
and its long term complications world-
wide. Further to this point, it’s also an
indicator for how much is the burden
of diabetic care on economy. Diagnosis
and treatment of diabetic neuropathy
is still a gray area. This filed lacks clear
guidelines for diagnosis and treatment.
Toward more accurate diagnosis, recently
the European Federation of Neurological
Studies recognized skin biopsy and nerve
density procedure as sensitive measures
of small fiber neuropathy (Lauria et al.,
2010). Different techniques have been
used to assess changes in neuropathy asso-
ciated with diabetes and that includes:
nerve conduction studies (for velocity and
amplitude), monofilaments is used mostly
for myelinated large fibers (assessment of
pressure, vibration and touch perception),
and skin biopsies. The latter followed by
immunohistochemistry are used in assess-
ment of unmyelinated fine C fibers. Other
methods such as using neurological scor-
ing systems are also valid tools in clinical
research of diabetic neuropathy, for details
please refer to Peltier et al., 2014.
It’s worth mentioning that despite the
significant information which could be
obtained by skin biopsy, this rout is not
a major rout used to confirm diagnosis
of neuropathy (Younger, 2010). No cure
is available for diabetic neuropathy and
all that could be offered to a patient is
different classes of drugs which are used
for symptomatic management of diabetic
pain or to slowdown the disease progress.
As partial nerve injury might be at the
core of the pathology, some very promis-
ing studies suggested the use of pluripotent
stem cells to repair the damaged nerve
(Mizukami and Yagihashi, 2014).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this
article can be found online at: http://www.
frontiersin.org/journal/10.3389/fnana.201
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